Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis (original) (raw)
References
Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MI (1994) Micronutrient antioxidant status in patients with primary Raynaud’s phenomenon and systemic sclerosis. J Rheumatol 21:1477–1483 PubMedCAS Google Scholar
Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G et al (2001) Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44:2653–2664 ArticlePubMedCAS Google Scholar
Butler AR, Flitney FW, Williams DL (1995) NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist’s perspective. Trends Pharmacol Sci 16:18–22 ArticlePubMedCAS Google Scholar
Suematsu M, Wakabayashi Y, Ishimura Y (1996) Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc Res 32:679–686 PubMedCAS Google Scholar
Andersen GN, Caidahl K, Kazzam E, Petersson AS, Waldenstrom A, Mincheva-Nilsson L et al (2000) Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 43:1085–1093 ArticlePubMedCAS Google Scholar
Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K et al (2006) Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. Rheumatology (Oxford) 45:815–818 ArticleCAS Google Scholar
Ogawa F, Shimizu K, Hara T, Muroi E, Hasegawa M, Takehara K et al (2008) Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage. Clin Exp Rheumatol 26:659–662 PubMedCAS Google Scholar
Thiele JJ, Schroeter C, Hsieh SN, Podda M, Packer L (2001) The antioxidant network of the stratum corneum. Curr Probl Dermatol 29:26–42 ArticlePubMedCAS Google Scholar
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84 ArticlePubMedCAS Google Scholar
Ogawa F, Sander CS, Hansel A, Oehrl W, Kasperczyk H, Elsner P et al (2006) The repair enzyme peptide methionine-S-sulfoxide reductase is expressed in human epidermis and upregulated by UVA radiation. J Invest Dermatol 126:1128–1134 ArticlePubMedCAS Google Scholar
Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C et al (1999) Oxidative stress in systemic sclerosis. Mol Cell Biochem 196:85–91 ArticlePubMedCAS Google Scholar
(1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581–590.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205 PubMedCAS Google Scholar
Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896 PubMedCAS Google Scholar
Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis. Arthritis Rheum 37:391–394 ArticlePubMedCAS Google Scholar
Nishijima C, Sato S, Hasegawa M, Nagaoka T, Hirata A, Komatsu K et al (2001) Renal vascular damage in Japanese patients with systemic sclerosis. Rheumatology (Oxford) 40:406–409 ArticleCAS Google Scholar
Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM, Gabriele S et al (2000) Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 155:1–15 ArticlePubMedCAS Google Scholar
Peng SL, Fatenejad S, Craft J (1997) Scleroderma: a disease related to damaged proteins? Nat Med 3:276–278 ArticlePubMedCAS Google Scholar
Iwata Y, Ogawa F, Komura K, Muroi E, Hara T, Shimizu K et al (2007) Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress. Rheumatology (Oxford) 46(5):790–795 ArticleCAS Google Scholar
Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C et al (2009) Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 182:5855–5864 ArticlePubMedCAS Google Scholar
Lundberg AC, Akesson A, Akesson B (1992) Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 51:1143–1148 ArticlePubMedCAS Google Scholar
Simonini G, Pignone A, Generini S, Falcini F, Cerinic MM (2000) Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis. Toxicology 155:1–15 ArticlePubMedCAS Google Scholar
Tikly M, Channa K, Theodorou P, Gulumian M (2006) Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol 25:320–324 ArticlePubMed Google Scholar
Morita A, Minami H, Sakakibara N, Sato K, Tsuji T (1996) Elevated plasma superoxide dismutase activity in patients with systemic sclerosis. J Dermatol Sci 11:196–201 ArticlePubMedCAS Google Scholar
Firuzi O, Fuksa L, Spadaro C, Bousova I, Riccieri V, Spadaro A et al (2006) Oxidative stress parameters in different systemic rheumatic diseases. J Pharm Pharmacol 58:951–957 ArticlePubMedCAS Google Scholar
Sfrent-Cornateanu R, Mihai C, Stoian I, Lixandru D, Bara C, Moldoveanu E (2008) Antioxidant defense capacity in scleroderma patients. Clin Chem Lab Med 46:836–841 ArticlePubMedCAS Google Scholar